Radiosensitivity Enhancement by Combined Treatment of Nimotuzumab and Celecoxib on Nasopharyngeal Carcinoma Cells

Drug Design, Development and Therapy - New Zealand
doi 10.2147/dddt.s163595
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

miR-206 Enhances Nasopharyngeal Carcinoma Radiosensitivity by Targeting IGF1

Kaohsiung Journal of Medical Sciences
Medicine
2017English

Cooperative Enhancement of Radiosensitivity After Combined Treatment of 17-(Allylamino)-17-Demethoxygeldanamycin and Celecoxib in Human Lung and Colon Cancer Cell Lines

DNA and Cell Biology
MedicineGeneticsCell BiologyMolecular Biology
2012English

Inhibition of ZIP4 Reverses Epithelial-To-Mesenchymal Transition and Enhances the Radiosensitivity in Human Nasopharyngeal Carcinoma Cells

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2019English

Suppression of Immune Regulatory Cells With Combined Therapy of Celecoxib and Sunitinib in Renal Cell Carcinoma

Oncotarget
Oncology
2016English

Experience With Combination of Nimotuzumab and Intensity-Modulated Radiotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

OncoTargets and Therapy
OncologyPharmacology
2015English

Effect of Sinomenine Hydrochloride on Radiosensitivity of Esophageal Squamous Cell Carcinoma Cells

Oncology Reports
MedicineCancer ResearchOncology
2018English

Growth Inhibition of Combined Treatment of Cationic Liposome/P53 Complexes and Cisplatin on Human Carcinoma Cells

Journal of Applied Pharmaceutical Science
MedicineToxicologyPharmaceuticsPharmacology
2020English

Combined Inhibitory Effects of Celecoxib and Fluvastatin on the Growth of Human Hepatocellular Carcinoma Xenografts in Nude Mice

Journal of International Medical Research
BiochemistryMedicineCell Biology
2010English

Nimotuzumab Combined With Chemotherapy Is a Promising Treatment for Locally Advanced and Metastatic Esophageal Cancer

Medical Science Monitor
Medicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy